Approval · Notice of Compliance 3463 · 2003
COVERSYL PLUS: Notice of Compliance 3463
Issued July 16, 2003
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3463
- Date
- July 16, 2003
- Company
- Servier Canada Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Admin
- Reason
- Change in product name from biprel
- Therapeutic class
- Angiotensin converting enzyme inhibitor/diuretic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COVERSYL PLUS | 02246569 | Marketed |
Medicinal ingredients
- PERINDOPRIL ERBUMINE 4 MG per TAB
- INDAPAMIDE 1.25 MG per TAB